Predicting Alzheimer’s disease risk by testing memory
Testing people’s memory over four weeks could help to identify who is at higher risk of developing Alzheimer’s disease.
New research, led by a team...
Research shows one in five people with multiple sclerosis now under 30
New research from the MS Society has revealed that one in five people diagnosed with Multiple Sclerosis are now under the age of 30.
The...
Call for urgent review of European prostate cancer care
A group of experts have called for an urgent review of prostate cancer care in Europe following the results of a first of its...
Increased risk of dying for rare autoimmune patients during COVID-19
A new study has shown that people living with rare autoimmune diseases are at heightened risk of dying during COVID-19, a finding that can...
Revolutionising the study of the cellular origins of disease
A breakthrough in microscopy and endoscopy is set to revolutionise how we study the cellular origin of diseases – advancing the field of precision...
Improving access to gene and cell therapies for people with rare diseases
A new report has addressed challenges to accessing gene and cell therapies for people living with rare diseases.
EURORDIS-Rare Diseases Europe and the partners of the...
Improving HIV testing in Europe
The European Centres for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) are calling for better HIV testing across Europe.
The ECDC...
Mammography screening srill vital for reducing breast cancer deaths
The NHS mammography Breast Screening Programme is still effective at reducing breast cancer-related death in England, according to a new study.
Led by the Queen...
Six months immunity following COVID-19 infection, say researchers
Immunity can last for up to six months following a COVID-19 infection, a new study has shown.
As part of a collaboration between the University...
Sleep disorder drug modafinil linked to increased risk of birth defects
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning to people using the sleep disorder drug modafinil while pregnant, due to an association with increased risk of birth defects.
Autistic children risk delays to diagnosis due to COVID-19 lockdowns
New research has shown that more than 128,000 children and their families risk being ‘forgotten’ by the system as lockdown causes delays in autism...
Non-hereditary mutation acts as natural gene therapy for GATA2 deficiency
Scientists have identified a non-inherited mutation in blood cells from a patient with GATA2 deficiency that may have prevented bone marrow failure and other...
Lung cancers detected early as a result of pioneering trial
A lung cancer trial, aiming to detect disease in higher risk patients before they show symptoms, has caught dozens of cases early.
Potential new medicine shows promise for patients with severe asthma
AstraZeneca and Amgen have announced positive results from the NAVIGATOR Phase III trial for a potential new medicine that could help patients with severe,...
MHRA to review acne treatment isotretinoin and suspected links with psychiatric and sexual side...
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a call for information on isotretinoin, a treatment for severe acne, which has been...
Potential new target for treating endometriosis discovered
Researchers have identified a potential target to treat a painful and invasive form of endometriosis.
Endometriosis, particularly the kind associated with the ARID1A mutation, can...
Jo’s Cervical Cancer Trust: cervical cancer in focus
Jo’s Cervical Cancer Trust Chief Executive Robert Music speaks to HEQ about cervical cancer screening, treatment, and research.
In the UK, around 3,200 new cases...
Trial shows positive results for reducing burden of stroke disability
Detailed results from an exploratory analysis of the THALES Phase III trial showed the medication Brilinta (ticagrelor) reduced the rate of the composite of...
Subarachnoid haemorrhage fatality rate higher than previously thought
A Finnish study has found that subarachnoid haemorrhage, an apparently rare form of stroke, is a more common cause of death than previously thought.
Subarachnoid...
Results from research programme could reduce global burden of leprosy
Results from the largest ever research programme combining contact tracing with prophylactic treatment show the approach could massively reduce the global burden of leprosy.
The...
